- Trials with a EudraCT protocol (78)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
78 result(s) found for: Spinal Cord Injury.
Displaying page 1 of 4.
EudraCT Number: 2012-005328-14 | Sponsor Protocol Number: SATIVEX-2013 | Start Date*: 2013-04-16 | |||||||||||||||||||||
Sponsor Name:Spinal Cord Injury Centre of Western Denmark | |||||||||||||||||||||||
Full Title: Effect of Sativex on neuropathic pain and spasticity following spinal cord injury | |||||||||||||||||||||||
Medical condition: Neuropathic pain and spasticity following spinal cord injury | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: DK (Prematurely Ended) | |||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2007-004358-10 | Sponsor Protocol Number: FARM6Y35XM | Start Date*: 2007-09-14 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERA OSPEDALE NIGUARDA CA' GRANDA (A.O. DI RILIEVO NAZIONALE) | |||||||||||||
Full Title: EVALUATION OF THE TOLERABILITY AND EFFICACY OF ERYTHROPOIETIN (EPO) TREATMENT IN SPINAL SHOCK: COMPARATIVE STUDY VS METHYLPREDNISOLONE (MP) | |||||||||||||
Medical condition: PARAPLEGICS AND TETRAPLEGICS | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-001227-31 | Sponsor Protocol Number: NISCI | Start Date*: 2019-06-19 | ||||||||||||||||
Sponsor Name:University Zurich, University Hospital Balgrist, Spinal Cord Injury Center | ||||||||||||||||||
Full Title: Antibodies against Nogo-A to enhance plasticity, regeneration and functional recovery after acute spinal cord injury | ||||||||||||||||||
Medical condition: spinal cord injury | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DE (Completed) CZ (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2006-006898-24 | Sponsor Protocol Number: 2006.455/48 | Start Date*: 2007-03-16 | |||||||||||
Sponsor Name:HOSPICES CIVILS DE LYON | |||||||||||||
Full Title: Etude TETRAM 2 : Traitement par l’Epo des TRAumatisés Médullaires : recherche de la dose maximum tolérée | |||||||||||||
Medical condition: traumatisme médullaire déficitaire (TMD) | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-005377-23 | Sponsor Protocol Number: SCI-GHD-201 | Start Date*: 2012-07-18 | ||||||||||||||||
Sponsor Name:Guillem Cuatrecasas Cambra | ||||||||||||||||||
Full Title: A phase II, single-center, prospective, randomized, double-blind, parallel and placebo-controlled pilot clinical study to assess the efficacy and safety of NUTROPIN® in combination with intensive r... | ||||||||||||||||||
Medical condition: Spinal Cord Injury and Growth Hormone Deficiency | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: ES (Completed) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-002211-25 | Sponsor Protocol Number: bot001 | Start Date*: 2013-04-08 |
Sponsor Name:Oslo University Hospital, Dept of Urology | ||
Full Title: Prevention of bladder dysfunction in acute spinal cord injury A double-blind, randomized, placebo-controlled study to explore the effect of early treatment with Onabotulinumtoxin A in patients ... | ||
Medical condition: Bladder dysfunction after acute spinal cord injury | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NO (Completed) | ||
Trial results: View results |
EudraCT Number: 2015-005717-80 | Sponsor Protocol Number: FAB117-CT-01 | Start Date*: 2016-05-29 | ||||||||||||||||
Sponsor Name:Ferrer Internacional S.A | ||||||||||||||||||
Full Title: Clinical trial of phase 1/2 to evaluate the feasibility, safety, tolerability and preliminary efficacy of the administration of FAB117-HC, a drug whose active ingredient is HC016, allogeneic adipos... | ||||||||||||||||||
Medical condition: Patients with acute traumatic spinal cord injury | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: ES (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-002170-36 | Sponsor Protocol Number: 2014-002170-36 | Start Date*: 2015-02-11 |
Sponsor Name:Karolinska University Hospital | ||
Full Title: Treatment of Cervical Spinal Cord Injury with Imatinib – a safety and feasibility study | ||
Medical condition: Cervical Spinal Cord Injury | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: SE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2014-003576-23 | Sponsor Protocol Number: GDX-44-004 | Start Date*: 2016-01-28 | ||||||||||||||||
Sponsor Name:GUERBET | ||||||||||||||||||
Full Title: P03277 Dose Finding Study in Central Nervous System (CNS) Magnetic Resonance Imaging (MRI) | ||||||||||||||||||
Medical condition: Subject presenting, at the time of inclusion, with known or highly suspected focal areas of disrupted Blood Brain Barrier (BBB) (e.g., primary and secondary tumors, focal inflammatory or demyelinat... | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: BE (Completed) CZ (Completed) HU (Completed) IT (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2012-003197-57 | Sponsor Protocol Number: A0081181 | Start Date*: 2012-11-09 | ||||||||||||||||||||||||||||||||||||
Sponsor Name:Pfizer Worldwide Research and Development | ||||||||||||||||||||||||||||||||||||||
Full Title: A MULTIPLE DOSE PHARMACOKINETIC OPEN-LABEL STUDY OF PREGABALIN (LYRICA) IN HEALTHY LACTATING WOMEN | ||||||||||||||||||||||||||||||||||||||
Medical condition: neuropathic pain associated with diabetic peripheral neuropathy postherpetic neuralgia neuropathic pain related to spinal cord injury (US), fibromyalgia (US, JP) treatment of central and periphe... | ||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||
Population Age: Adults | Gender: Female | |||||||||||||||||||||||||||||||||||||
Trial protocol: BE (Completed) | ||||||||||||||||||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2011-005684-24 | Sponsor Protocol Number: CME-LEM2 | Start Date*: 2014-01-16 | |||||||||||
Sponsor Name:Fundación Investigación Biomédica Hospital Universitario Puerta de Hierro | |||||||||||||
Full Title: Subarachnoid administration of autologous bone marrow stromal cells in incomplete spinal cord injury. | |||||||||||||
Medical condition: Incomplete spinal cord injury, due to traumatical or ischemic cause. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-005786-23 | Sponsor Protocol Number: XCEL-SCI-01 | Start Date*: 2016-04-20 | |||||||||||
Sponsor Name:Banc de Sang i Teixits | |||||||||||||
Full Title: A phase I/IIa, randomized, double-blind, single-dose, placebo controlled, two-way crossover clinical trial to assess the safety and to obtain efficacy data in intrathecal administration of expanded... | |||||||||||||
Medical condition: Chronic traumatic spinal cord injury | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-002130-72 | Sponsor Protocol Number: 8845 | Start Date*: 2016-08-08 |
Sponsor Name:Division of Thoracic and Hyperbaric Surgery, Medical University Graz | ||
Full Title: Hyperbaric Oxygenation (HBO) in traumatic spinal cord injury. | ||
Medical condition: We want to investigate the effect of hyperbaric oxygen therapy on the neurological and clinical outcome following traumatic injury of the spinal cord. | ||
Disease: | ||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2018-004679-11 | Sponsor Protocol Number: 0604 | Start Date*: 2020-04-21 |
Sponsor Name:Division of Thoracic and Hyperbaric Surgery, Medical University Graz | ||
Full Title: Hyperbaric Oxygenation (HBO) in traumatic spinal cord injury - prospective study with 100 patients. | ||
Medical condition: We want to investigate the effect of hyperbaric oxygen therapy on the neurological and clinical outcome following traumatic injury of the spinal cord. | ||
Disease: | ||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2021-000346-18 | Sponsor Protocol Number: BST-SCI-02 | Start Date*: 2021-06-28 | |||||||||||
Sponsor Name:Banc de Sang i Teixits | |||||||||||||
Full Title: A phase I/II, randomized, double-blind, placebo-controlled, parallel, 2-arms clinical trial to assess the safety and efficacy of intrathecal administration of WJ-MSC in chronic traumatic cervical i... | |||||||||||||
Medical condition: Cronic traumatic spinal cord injury | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2022-000788-30 | Sponsor Protocol Number: 1.2022 | Start Date*: 2023-04-13 |
Sponsor Name:Uzdrowisko Kamień Pomorski S.A. | ||
Full Title: Evaluation of the effectiveness of Methocarbamol in the treatment of spasticity in people with spinal cord injury. | ||
Medical condition: | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: PL (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2019-003752-36 | Sponsor Protocol Number: M16-077 | Start Date*: 2020-05-14 | |||||||||||
Sponsor Name:AbbVie Deutschland GmbH & Co. KG | |||||||||||||
Full Title: A Randomized, Double-Blind, Placebo-Controlled Proof of Concept Study to Assess the Safety and Efficacy of Elezanumab in Acute Traumatic Cervical Spinal Cord Injury | |||||||||||||
Medical condition: Spinal cord injury (SCI) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-008339-27 | Sponsor Protocol Number: A0081107 | Start Date*: 2009-05-07 | |||||||||||
Sponsor Name:Pfizer Inc., 235 East 42nd Street, New York, NY10017 | |||||||||||||
Full Title: A 17-WEEK, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, MULTI-CENTER TRIAL OF PREGABALIN FOR THE TREATMENT OF CHRONIC CENTRAL NEUROPATHIC PAIN AFTER SPINAL CORD INJURY | |||||||||||||
Medical condition: Chronic Central Neuropathic Pain after Spinal Cord Injury. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-003171-21 | Sponsor Protocol Number: LEV-2005 | Start Date*: 2005-11-02 |
Sponsor Name:Danish Pain Research Center | ||
Full Title: Effect of levetiracetam in spinal cord injury pain: a randomized, double-blind, placebo-controlled crossover study | ||
Medical condition: Neuropathic pain following spinal cord injury | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DK (Completed) | ||
Trial results: View results |
EudraCT Number: 2022-001522-30 | Sponsor Protocol Number: RIMOFATSCI-2 | Start Date*: 2022-10-03 |
Sponsor Name:Fundación Hospital Nacional de Parapléjicos | ||
Full Title: Effects of a CB1 receptor reverse antagonist/agonist (Rimonabant) on wandering ability in patients with incomplete spinal cord injuries | ||
Medical condition: Possibility of improving wandering in patients. The effects of Rimonabant on other functional measures will be assessed and it will be confirmed that it is a safe treatment in the study population. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
